ForumIAS LATEST
- SFG FRC 2027 | Program starts from 19th Dec. 2026 | Admissions open for Entrance Test Click Here to know more →
- Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
- [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 10th October onwards Click Here to Read More →
- 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →
What is the News?
The Ministry of Ayush has announced that it has taken steps to increase the production of AYUSH 64 across the country to treat mild to moderate cases of coronavirus infections.
About Ayush-64:
- Ayush-64 is an Ayurvedic drug developed by the Central Council for Research in Ayurvedic Sciences(CCRAS), the apex body for research in Ayurveda under the Ministry of Ayush.
- The drug was originally developed in 1980 for the management of Malaria.
- However, this drug has now been repurposed for Covid-19 as its ingredients showed notable antiviral, immune-modulator, and antipyretic properties.
- The drug can be useful for the treatment of asymptomatic, mild, and moderate COVID-19 infection cases.
- The drug was found to significantly enhance the recovery in terms of disease symptoms and severity. It also has significant beneficial effects on general health, fatigue, anxiety, stress, appetite, general wellbeing, and sleep.
- Ayush-64 is a polyherbal formulation i.e. use of more than one herb. The development of the drug was in compliance with all regulatory requirements of pharmacopeial standards by the Central Council for Research in Ayurvedic Sciences (CCRAS)
Source: PIB
